Capmatinib
id:
capmatinib-247-5645868
title:
Capmatinib
text:
Capmatinib, sold under the brand name Tabrecta, is an anticancer medication used for the treatment of metastatic non-small cell lung cancer whose tumors have a mutation that leads to the exon 14 skipping of the MET gene, which codes for the membrane receptor HGFR. The most common adverse reactions are peripheral edema, nausea, fatigue, vomiting, dyspnea, and decreased appetite. Non-small cell lung cancer is a disease in which malignant cancer cells form in the tissues of the lung. It is the most
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Capmatinib
date created:
date modified:
2024-03-14T23:58:03Z
main entity:
{"identifier":"Q27075685","url":"https://www.wikidata.org/entity/Q27075685"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/73/Capmatinib.svg","width":512,"height":240}
fields total:
13
integrity:
15